Boswellia Serrata Extract

Product Specifications

Botanical SourceClean, authentic oleo-gum resin exuded from the bark of Boswellia serrata Roxb. ex Colebr. (Family: Burseraceae; Indian Frankincense / Salai Guggul / 印度乳香)
Part UsedResin
SpecificationBoswellic Acids 65% 90%
AppearanceOff-White to Yellow-Brown Fine Powder

Targeted Botanical Anti-Inflammatory Active & Master 5-LOX Inhibitor extracted from the wild-harvested oleo-gum resin of Boswellia serrata Roxb. ex Colebr. Standardized specifically to pentacyclic triterpenic boswellic acids—featuring high-potency AKBA (3-O-Acetyl-11-keto-β-boswellic acid up to 30% by HPLC) and Total Boswellic Acids up to 85%. Formulated to selectively inhibit 5-lipoxygenase (5-LOX), block pro-inflammatory leukotriene (LTB4) synthesis, prevent synovial cartilage breakdown by matrix metalloproteinases (MMPs), and support gastrointestinal mucosal integrity. Serves as the premier raw material for joint mobility & osteo-relief capsules, gut barrier anti-inflammatory formulas, sports exercise recovery tablets, and adaptogenic mobility beverage mixes.

REQUEST A QUOTE

Boswellia Serrata Extract (Total Boswellic Acids ≥65%-85% / AKBA ≥10%-30% HPLC) | Benchmark Botanical 5-LOX Inhibitor for Joint Mobility & Inflammatory Harmony

1. Product Overview & Value Proposition

Boswellia Serrata Extract (Indian Frankincense, Boswellia serrata, 齿叶乳香提取物 / 乳香酸), prepared from the purified oleo-gum resin tapping of the dry deciduous tree native to the arid hills of India and regional arid zones, represents the premier clinical botanical active in joint health pharmacology, targeted leukotriene modulation, and connective tissue preservation. The targeted biological efficacy of Boswellia serrata extract powder is driven specifically by its unique family of pentacyclic triterpenic acids, collectively known as Boswellic Acids: α-boswellic acid, β-boswellic acid, 3-O-acetyl-α-boswellic acid, 3-O-acetyl-β-boswellic acid, 11-keto-β-boswellic acid (KBA), and the single most pharmacologically potent homologue, 3-O-Acetyl-11-keto-β-boswellic acid (AKBA).

Unlike standard non-steroidal anti-inflammatory agents (NSAIDs) that non-selectively block cyclooxygenase-1 and cyclooxygenase-2 (COX-1/COX-2)—frequently precipitating gastrointestinal ulceration and mucosal thinning—boswellic acids, particularly AKBA, act as selective, non-redox allosteric inhibitors of 5-Lipoxygenase (5-LOX). By preventing the incorporation of arachidonic acid into 5-LOX without generating pro-oxidant radicals, boswellic acids halt the enzymatic cascade that produces pro-inflammatory Leukotriene B4 (LTB4) and cysteinyl leukotrienes. This targeted pathway prevents neutrophil chemotaxis, downregulates matrix metalloproteinases (MMP-3, MMP-9, MMP-13) that degrade type II collagen and aggrecan in articular cartilage, and shields gastrointestinal epithelial junctions. Our bulk Boswellia serrata extract delivers consistent high-performance formulations across key commercial categories:

  • Clinical Joint Comfort & Cartilage Protection Formulations: Highly concentrated AKBA and total boswellic acids clinically shown to ease joint stiffness, improve flexion mobility, and alleviate weight-bearing knee discomfort in as few as 5 to 7 days.
  • Intestinal Mucosal & Gut Barrier Support: Downregulates mucosal leukotrienes and nuclear factor kappa B (NF-κB) transcription, providing a non-irritating botanical intervention for compromised bowel and gastrointestinal linings.
  • Post-Exercise Sports Recovery & Tendon Mobility: Modulates delayed-onset connective tissue soreness (DOMS), blunts systemic inflammatory markers (hs-CRP, TNF-α), and accelerates muscular and ligament recovery following high-impact training.
  • Functional Lifestyle Beverages & Drink Sticks: Available in microencapsulated Cold-Water-Dispersible (CWS) formats that bypass native gum stickiness, dissolving smoothly into ready-to-mix joint tonics, mobility stick packs, and adaptogenic coffees without oily residue.

As an established bulk Boswellia Serrata Extract manufacturer and direct botanical active supplier, we process sustainably tapped oleo-gum resin using clean food-grade hydro-ethanolic extraction, selective chromatographic resin purification, and vacuum spray crystallization. To empower agile brands and contract manufacturing organizations (CMOs), we pair uncompromising analytical quality with flexible commercial terms: accessible low MOQ procurement for benchtop pilot trials, multi-ingredient shipment consolidation across our joint botanical, longevity vitamin, and adaptogenic fungal catalog, and dedicated on-the-ground China-wide raw material sourcing assistance tailored to your exact manufacturing requirements.

2. Product Specifications (Analytical Quality)

Test Item Standard Grade (Boswellic Acids 65%) High-Assay Grade (Boswellic Acids 85%) High-AKBA Grade (AKBA ≥30% HPLC) Test Method
Botanical Identification Conforms to authentic Boswellia serrata Gum Resin Chromatographic Profile TLC / HPTLC / HPLC Fingerprint
Total Boswellic Acids Assay ≥ 65.00% (Titration / HPLC) ≥ 85.00% (Titration / HPLC) ≥ 60.00% – 70.00% Titrimetric / HPLC-UV (USP/EP)
AKBA Content (on Dry Basis) 1.00% – 3.00% 3.00% – 5.00% ≥ 30.00% (Standardized Active Target) HPLC-UV (at 250 nm)
11-Keto-β-Boswellic Acid (KBA) Present naturally (≥ 1.0%) ≥ 2.00% ≥ 5.00% – 10.00% HPLC-UV
Appearance & Color Fine off-white to light creamy-yellow powder Light creamy-white fine powder Light yellow-beige to tan fine powder Visual / Organoleptic
Odor & Taste Characteristic pleasant aromatic, balsamic, faint woody aroma; clean, slightly bitter taste Organoleptic
Solubility & Dispersibility Lipophilic (soluble in ethanol, fixed oils); CWS grade 100% dispersible in water Visual / Turbidimetry
Particle Size 100% passing 80 mesh (Uniform powder flowability for encapsulation) Sieve Analysis
Loss on Drying / Moisture ≤ 5.00% Gravimetric (105°C)
Total Ash / Residue on Ignition ≤ 5.00% (Ph. Eur. ≤ 8.0%) Gravimetric (600°C)
Heavy Metals (Pb) < 1.0 ppm (As < 1.0 ppm, Cd < 0.5 ppm, Hg < 0.1 ppm) ICP-MS
Residual Solvents (Ethanol) ≤ 5,000 ppm (Complies with USP <467> / EP Option 1 guidelines) GC-HS
Microbiological Limits Total Plate Count ≤ 1,000 CFU/g; Yeast & Mold ≤ 100 CFU/g; Pathogens Absent USP/EP Standard

3. Functional Applications (Mechanism of Action)

Deploying standardized Boswellic Acids and concentrated AKBA across joint care, sports recovery, and digestive wellness formulations provides scientifically verified cellular mechanisms:

  • Selective Non-Redox Inhibition of 5-Lipoxygenase (5-LOX): AKBA (3-O-acetyl-11-keto-β-boswellic acid) binds directly to a distinct allosteric site on the 5-LOX enzyme. Unlike synthetic redox-type inhibitors that cause oxidative cellular side effects, AKBA locks 5-LOX in an inactive state without generating free radicals, halting the synthesis of pro-inflammatory Leukotriene B4 (LTB4) and cysteinyl leukotrienes.
  • Inhibition of Synovial Matrix Metalloproteinases (MMPs): Inflammatory joint stress upregulates matrix metalloproteinases that degrade structural cartilage. Boswellic acids downregulate the gene expression and enzymatic activity of MMP-3 (stromelysin-1), MMP-9, and MMP-13 (collagenase-3), preventing the cleavage of articular type II collagen fibers and aggrecan proteoglycans in synovial joints.
  • NF-κB Downregulation & Cytokine Suppression: Boswellic acids block the phosphorylation and degradation of IκB-alpha, preventing the nuclear translocation of Nuclear Factor Kappa B (NF-κB). This shuts down transcription of pro-inflammatory cytokines, including Tumor Necrosis Factor-alpha (TNF-α), Interleukin-1 beta (IL-1β), and Interleukin-6 (IL-6).
  • Rapid Joint Flexion & Mobility Enhancement: Multiple double-blind, randomized controlled clinical trials confirm that supplementing 100 mg to 250 mg of high-AKBA Boswellia extract daily produces statistically significant reductions in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scores within 5 to 7 days, reducing knee joint pain, morning stiffness, and walking discomfort.
  • Intestinal Epithelial Barrier & Mucosal Defense: By blunting local 5-LOX leukotriene cascades and reducing leukocyte infiltration into intestinal mucosa, boswellic acids preserve tight junction proteins (occludin, claudin-1), alleviate mucosal hyperemia, and soothe digestive discomfort without the gastric ulceration risks linked to pharmaceutical NSAIDs.
  • Aromatic Balance in Functional Mobility “Mushroom Coffee”: Microencapsulated CWS Boswellia Extract features a pleasant, warm, balsamic herbal aroma that blends smoothly into dark roasted coffee, cacao, and functional mushroom extracts (like Cordyceps and Reishi). It masks fungal bitterness, adds a clean aromatic body, and provides daily joint anti-inflammatory defense in an everyday morning beverage format.

4. Formulation Combinations & Trending Market Applications

Capitalize on the expanding healthy aging joint mobility, sports recovery, and functional beverage markets by formulating with our specialized Boswellic Acid portfolio:

  • The Master Clinical “Fast-Acting 5-Day Joint Relief” Matrix: Our High-AKBA Boswellia Extract (AKBA ≥30%, 100 mg) + Curcumin (95% Curcuminoids, 500 mg) + BioPerine (Piperine 95%, 5 mg) + Undenatured Type II Collagen (UC-II, 40 mg) + Hyaluronic Acid (Sodium Hyaluronate, 50 mg). The gold-standard clinical joint synergy: AKBA selectively blocks the 5-LOX pathway while Curcumin downregulates COX-2, UC-II retrains oral immune tolerance against cartilage breakdown, and Hyaluronate lubricates synovial fluid.
  • The Advanced Glucosamine & Chondroitin Synergy Tablet: Our Boswellia Serrata Extract (Boswellic Acids 65%–85%, 250 mg) + Glucosamine Sulfate 2KCl (1,500 mg) + Chondroitin Sulfate Sodium (≥90%, 800 mg) + MSM (Methylsulfonylmethane, 1,000 mg). A comprehensive musculoskeletal formulation combining structural cartilage building blocks (Glucosamine/Chondroitin/MSM) with rapid-acting enzymatic 5-LOX inhibition (Boswellia) to relieve chronic joint discomfort.
  • The Intestinal Mucosal Barrier & Gut Comfort Complex: Our Boswellia Serrata Extract (High-AKBA 20%, 150 mg) + Deglycyrrhizinated Licorice Extract (DGL 10:1, 300 mg) + L-Glutamine (1,000 mg) + Zinc Carnosine (75 mg) + Slippery Elm Bark Extract (10:1, 200 mg). A soothing gastrointestinal capsule designed to downregulate mucosal leukotrienes, support epithelial tight junctions, and calm digestive inflammation.
  • The Trending “Mobility & Morning Energy” Mushroom Coffee Blend: Our Water-Dispersible CWS Boswellia Extract (20% Boswellic Acids, 200 mg) + Cordyceps Militaris Extract (Cordycepin 1%, 300 mg) + Lion’s Mane Mushroom Extract (Beta-Glucan 30%, 300 mg) + Ginger Root Extract (5% Gingerols, 100 mg) + Micro-Ground Arabica Coffee. An elite functional morning brew engineered to protect joint cartilage, sustain cellular ATP stamina, and ease morning physical stiffness without digestive upset.

5. Why Choose Us As Your Long-Term Botanical Active Partner?

  • Flexible Low MOQ Policy: Mitigate product launch risk. As an agile low MOQ Boswellia serrata extract supplier, our orders start as low as 1 kg for standardized powders (65%–85% Boswellic Acids), high-potency AKBA grades (10%–30%), and water-dispersible CWS powders, scaling seamlessly to recurring multi-ton commercial container contracts.
  • Multi-Product Portfolio Consolidation: Streamline your supply chain by sourcing your complete joint mobility and anti-inflammatory suite (Boswellia Serrata, Curcumin 95%, Type II Collagen, Glucosamine, Chondroitin, MSM), adaptogenic mushrooms (Cordyceps, Lion’s Mane, Reishi), and longevity actives under a single, cost-effective freight shipment to reduce customs overhead and landed freight costs.
  • Value-Added China Sourcing Service: In addition to our dedicated solvent extraction and crystallization facilities, our on-the-ground technical team audits upstream raw gum-resin imports, validates HPLC AKBA and titrimetric testing paperwork, and procures specialized functional ingredients across China tailored to your exact manufacturing roadmap.

6. Quality & Supply Chain Assurance

  • Authentic Wild Oleo-Gum Resin Sourcing: Sourced strictly from verified wild collections of mature Boswellia serrata gum resin tapping, eliminating mixed resin adulterants (such as Boswellia carterii or non-boswellic pine resins) to guarantee authentic pentacyclic triterpene distribution.
  • Clean Closed-Loop Hydro-Ethanolic Extraction: Manufactured using automated closed-loop aqueous ethanol extraction followed by resin-oil separation, low-temperature vacuum crystallization, and spray drying. Completely free from hazardous petrochemical solvents (such as hexane, chloroform, or benzene) to ensure residual solvents comply with USP <467> and EP guidelines.
  • Validated HPLC AKBA & Titration Standardization: Every commercial batch is tested against certified reference standards using high-performance liquid chromatography (HPLC-UV at 250 nm) for AKBA and KBA, alongside pharmacopeial titrimetric verification for total boswellic acids, ensuring exact active quantification and reliable batch-to-batch repeatability.
  • CWS Microencapsulation Technology: Native boswellia resins are hydrophobic and naturally sticky. Our water-dispersible CWS grade utilizes food-grade modified starch and acacia gum matrices to microencapsulate the resinous acids, ensuring smooth bulk density, excellent flowability for automated capsule encapsulation, and instant aqueous dispersion without clumping.
  • Comprehensive ICP-MS & Pesticide Screening: Batch-tested via high-resolution ICP-MS and GC-MS/MS to ensure heavy metals (Lead, Arsenic, Cadmium, Mercury) and agrochemical residues strictly comply with California Prop 65, USP <561>, and European Union food supplement pharmacopeial standards. Sealed in food-grade, vacuum-packed double-polyethylene liners within heavy-duty 25 kg fiber export drums.

7. FAQ

Q1: What is the biological difference between “Total Boswellic Acids 65%” and “AKBA 30%”?
A1: Total Boswellic Acids represents the broad quantitative sum of all six major pentacyclic triterpenic acids found in the gum resin (including α- and β-boswellic acids and their acetylated forms). AKBA (3-O-acetyl-11-keto-β-boswellic acid) is the single most pharmacologically potent molecule within this group. While standard total boswellic acids provide broad-spectrum anti-inflammatory benefits, concentrated AKBA (10%–30% by HPLC) specifically and potently targets the 5-LOX enzyme allosteric site, allowing formulators to achieve rapid clinical joint comfort at significantly lower milligram doses (100–250 mg/day vs. 500–1,000 mg/day).

Q2: Why is Boswellia Serrata preferred over standard NSAIDs for long-term joint health?
A2: Standard NSAIDs (like ibuprofen) inhibit cyclooxygenase enzymes (COX-1 and COX-2). Prolonged COX-1 inhibition depletes protective gastric prostaglandins, frequently triggering stomach mucosal erosion, ulcers, and intestinal permeability. Boswellia serrata specifically inhibits 5-lipoxygenase (5-LOX) without disrupting the protective COX-1 pathway, providing joint comfort and cartilage protection while protecting the gastrointestinal lining.

Q3: How does Boswellia Serrata Extract synergize with Curcumin in joint formulations?
A3: Combining Boswellia with Curcumin delivers the gold-standard “dual-pathway” anti-inflammatory synergy: Curcumin predominantly targets cyclooxygenase-2 (COX-2) and downstream prostaglandin synthesis, while Boswellia (via AKBA) specifically inhibits 5-lipoxygenase (5-LOX) and leukotriene LTB4 formation. By neutralizing both major inflammatory cascades simultaneously, the combination delivers faster and more durable relief than either botanical alone.

Q4: What is the recommended daily dosage of Boswellia Serrata Extract in finished products?
A4: Clinical dosages vary by active specification and target application:

  • Standardized Boswellic Acids (65%–85%): 400 mg to 1,000 mg per day (typically divided into two or three doses with meals).
  • High-AKBA Extracts (20%–30% AKBA): 100 mg to 250 mg per day (delivering rapid-acting clinical joint comfort).
  • Gut Mucosal & Barrier Complexes: 150 mg to 300 mg daily.
  • Functional Mobility Coffees & Beverages: 100 mg to 200 mg per serving (using our water-soluble CWS powder).

Q5: What is the MOQ for bulk Boswellia Serrata Extract orders?
A5: We support agile commercialization with minimum order quantities starting from just 1 kg for standardized powders (65%–85% Boswellic Acids), high-potency AKBA grades (10%–30%), and water-dispersible CWS grades, scaling smoothly up to recurring multi-ton commercial container contracts.

8. References

  1. PubChem: 3-O-Acetyl-11-keto-β-boswellic acid Compound Summary (CID 11954310) – National Center for Biotechnology Information.
  2. PubMed Central: Boswellia Serrata Extract in the Management of Osteoarthritis and Inflammation: A Systematic Review and Meta-Analysis of Randomized Clinical Trials – National Institutes of Health research database.

Keywords you may search: bulk Boswellia Serrata Extract supplier, Boswellia serrata gum resin manufacturer, boswellic acids 65 percent bulk, pure AKBA 30 percent HPLC, 5-LOX inhibitor joint raw material, water soluble boswellia serrata CWS, osteoarthritis botanical active ingredient, low MOQ joint health ingredient provider, custom China ingredient sourcing service, pure boswellia serrata bulk